270 results on '"Vukovic, V."'
Search Results
2. A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)
3. Determinants of intention to work abroad of college and specialist nursing graduates in Serbia
4. ALRN 6924 induces cell cycle arrest in bone marrow stem cells and hair follicles with dose-dependent degree and duration of effects after a single infusion in healthy volunteers
5. Survival, recurrence and second primary malignancies in HNC cancer: a multicentre study: Roberta Pastorino
6. Identifying elderly with low vaccine uptake using social deprivation indices: a systematic review: Vladimir Vukovic
7. A rush to explore protein–ligand electrostatic interaction energy with Charger
8. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
9. PB2162: INCREASED OXIDATIVE STRESS IN DIFFUSE LARGE B-CELL LYMPHOMA
10. PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
11. P1694: THROMBOSIS RISK ASSESSMENT IN LYMPHOMA PATIENTS - PROSPECTIVE PILOT SUDY
12. PB2086: CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS WITH LIVER INFILTRATION
13. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
14. Lipidomics, Atrial Conduction, and Body Mass Index: Evidence From Association, Mediation, and Mendelian Randomization Models
15. Italian contribution to University Autonomy in Kazakhstan: the Erasmus+ project “Transition to University Autonomy in Kazakhstan” (TRUNAK)
16. 1791P A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers
17. 1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
18. Review of heat demand time series generation for energy system modelling
19. ULTRASONOGRAPHY OF THE OPTIC NERVE SHEATH IN BRAIN DEATH: P72
20. Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924
21. Distinguishing Parkinsonʼs disease and essential tremor with transcranial sonography
22. When politicians collude with firms: the impact of elite networks on inequality
23. The International Conference on Energy and Sustainable Futures (ICESF): Nottingham Trent University, Nottingham, 9 to 11 September 2019
24. 136 (PB126) - ALRN 6924 induces cell cycle arrest in bone marrow stem cells and hair follicles with dose-dependent degree and duration of effects after a single infusion in healthy volunteers
25. Analysis of influenza vaccination coverage among the elderly living in Rome, based on a deprivation index, 2009-2013
26. A phase IIa clinical trial combining ALRN-6924 and palbociclib for the treatment of patients with tumours harboring wild-type p53 and MDM2 amplification or MDM2/CDK4 co-amplification
27. PB2278 PRETREATMENT SERUM 25(OH) VITAMIN D AS PREDICTOR OF EVENT- FREE SURVIVAL IN LYMPHOID MALIGNANCIES
28. PB1902 THE BARCELONA-BRNO BIOMARKERS-ONLY PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA - SINGLE CENTRE EXPERIENCE
29. S1645 NEUTROPHIL TO LYMPHOCYTE RATIO, PLATELET TO LYMPHOCYTE RATIO, AND RISK OF THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY
30. NEUTROPHIL TO LYMPHOCYTE RATIO, PLATELET TO LYMPHOCYTE RATIO, AND RISK OF THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY
31. PB1908 THE SIGNIFICANCE OF THE INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI) IN SERBIAN CLL PATIENTS
32. HEALTH TECHNOLOGY ASSESSMENT EVIDENCE on E-HEALTH/M-HEALTH TECHNOLOGIES: EVALUATING the TRANSPARENCY and THOROUGHNESS
33. HTA applicato alla pianificazione, alla programmazione e all'organizzazione sanitaria
34. INDICI DI DEPRIVAZIONE SOCIO-ECONOMICO SANITARI E STATO DI SALUTE DEGLI OVER65: PRIMI RISULTATI
35. Does public reporting influence quality, patient and provider's perspective, market share and disparities? A review
36. CHRONIC LYMPHOCYTIC LEUKEMIA INVOLVEMENT OF CENTRAL NERVOUS SYSTEM: A SINGLE CENTRE EXPERIENCE
37. COMPARATIVE ANALYSIS OF PREDICTIVE MODELS FOR THROMBOEMBOLIC EVENTS IN LYMPHOMA PATIENTS
38. Achievement of complete remission after autologous stem cell transplantation is strongly corelated with improved survival of patients with Hodgkin lymphoma
39. Pitfalls of positivity–new perspectives on the futility of negating negativity
40. P-051: Thrombosis lymphoma score performance in female population
41. Clinical features and prognostic factors in patients with head and neck cancer – Results from a multicentric study
42. 475P - A phase IIa clinical trial combining ALRN-6924 and palbociclib for the treatment of patients with tumours harboring wild-type p53 and MDM2 amplification or MDM2/CDK4 co-amplification
43. Development of acid-labile immunoconjugates for tumor-specific activation of cytotoxins
44. Changes in Quality, Market Share and Disparities after Performance Publication: A Systematic Review
45. Assessing health technologies through the HTA approach: the basic methodology to be used
46. The HTA evidence on e-health/m-health: which challenges?
47. Economic impact of schizophrenia on health systems
48. OC-07 - Decoding risk for thromboembolic events in lymphoma patients
49. Soft neurological signs in schizoaffective disorder – Indicator of psychotic spectrum or diagnostic bias (case report)
50. Importance of proper nutrition during pregnancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.